Gunyana 8, 2025, InnoCare Pharma yakazivisa kuti HIBRUKA (orelabrutinib) yakatenderwa neHealth Sciences Authority (HSA) yeSingapore kurapa varwere vakuru vane relapse or refractory marginal zone lymphoma (R/R MZL).
Parizvino, kuchine miedzo yakawanda yekiriniki yehunyanzvi hutsva hwekurwisa gomarara muChina huri kutsvaga varwere. Kana muchida kubvunzana nezvemishonga mitsva netekinoroji, munogona kubata Dhipatimendi reBeijing South Region Oncology Hospital International.
Nhamba yefoni: 4008803716
Nhamba yeWeChat: 17801183037
Email：myimmnet@163.com
Marginal zone lymphoma (MZL) iB-cell non-Hodgkin's lymphoma (NHL) inongogara ichibata varwere vezera repakati nepakati nevakuru. Kuwanda kweMZL pagore kuri kuwedzera pasi rose. Mushure mekurapwa kwekutanga, varwere vane R/R MZL vanoshaya nzira dzinoshanda dzekurapa.
Muna Kubvumbi 2025, orelabrutinib yakagamuchira mvumo muChina yekurapa varwere vane chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL). Orelabrutinib yakatenderwawo kurapa zvimwe zviratidzo zvitatu muChina, zvinosanganisira relapse and refractory (R/R) CLL/SLL, r/r mantle cell lymphoma (R/R MCL) uye r/r marginal zone lymphoma (R/R MZL), zvese izvi zvakaverengerwa muNational Reimbursement Drug List yeChina.
Kushanda, Kuchengeteka, uye Ruzivo rweOrelabrutinib Plus Obinutuzumab muSystemic Treatment-Naive Marginal Zone Lymphoma: Chidzidzo cheProspective Cohort chakaratidza kuti Mukati mekudzidza kwese uye panguva yekurapwa neinduction, huwandu hwemhinduro (ORR) hwakasvika 100%. Varwere vatatu vane partial response (PR) mushure meinduction therapy vakawana complete response (CR) panguva yekuchengetedza.
Kuongororwa kweADCC kwakaratidza kuti orelabrutinib pamwe chete neobinutuzumab regimen zvakakonzera mhinduro yeADCC inoshanda zvakanyanya mumasero eTMD-8 neREC-1.
Parizvino, kuchine miedzo yakawanda yekiriniki yehunyanzvi hutsva hwekurwisa gomarara muChina huri kutsvaga varwere. Kana muchida kubvunzana nezvemishonga mitsva netekinoroji, munogona kubata Dhipatimendi reBeijing South Region Oncology Hospital International.
Nhamba yefoni: 4008803716
Nhamba yeWeChat: 17801183037
Email：myimmnet@163.com
Nguva yekutumira: Gunyana-09-2025